Labiana Health S.A [LAB] vs Almirall S.A [ALM] Detailed Stock Comparison
Labiana Health S.A
BME
Loading...
Almirall S.A
BME
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Labiana Health S.A wins in 12 metrics, Almirall S.A wins in 5 metrics, with 0 ties. Labiana Health S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Labiana Health S.A | Almirall S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 104.00 | 116.00 | Labiana Health S.A |
| Price-to-Book Ratio | 6.26 | 1.70 | Almirall S.A |
| Debt-to-Equity Ratio | 1,378.08 | 26.47 | Almirall S.A |
| PEG Ratio | N/A | 25.22 | N/A |
| EV/EBITDA | 6.18 | 14.14 | Labiana Health S.A |
| Profit Margin (TTM) | 0.38% | 2.02% | Almirall S.A |
| Operating Margin (TTM) | 3.32% | 3.22% | Labiana Health S.A |
| EBITDA Margin (TTM) | 3.32% | 3.22% | Labiana Health S.A |
| Return on Equity | 6.92% | 1.45% | Labiana Health S.A |
| Return on Assets (TTM) | 5.72% | 1.56% | Labiana Health S.A |
| Free Cash Flow (TTM) | $4.15M | $-664,000 | Labiana Health S.A |
| Dividend Yield | N/A | 1.67% | N/A |
| 1-Year Return | 60.00% | 31.07% | Labiana Health S.A |
| Price-to-Sales Ratio (TTM) | 0.45 | 2.36 | Labiana Health S.A |
| Enterprise Value | $57.54M | $2.53B | Almirall S.A |
| EV/Revenue Ratio | 0.87 | 2.40 | Labiana Health S.A |
| Gross Profit Margin (TTM) | 147.79% | 91.07% | Labiana Health S.A |
| Revenue per Share (TTM) | N/A | $5 | N/A |
| Earnings per Share (Diluted) | $0.04 | $0.10 | Almirall S.A |
| Beta (Stock Volatility) | -0.39 | 0.34 | Labiana Health S.A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Labiana Health S.A vs Almirall S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Labiana Health S.A | 1.50% | 0.00% | 2.04% | 9.89% | 35.14% | 36.05% |
| Almirall S.A | -1.90% | 3.76% | 3.57% | 9.23% | 14.51% | 38.42% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Labiana Health S.A | 60.00% | 13,233.33% | 640.74% | 400.00% | 400.00% | 400.00% |
| Almirall S.A | 31.07% | 17.65% | 20.08% | -26.40% | 40.61% | -22.77% |
News Based Sentiment: Labiana Health S.A vs Almirall S.A
Labiana Health S.A
News sentiment data is not available for Labiana Health S.A at this time.
Almirall S.A
News based Sentiment: POSITIVE
Almirall had a very positive month, showcasing significant advancements in its dermatology pipeline at the EADV Congress. This was reflected in a stock price increase of 1.78% and the stock nearing its 52-week high. The positive clinical data and pipeline developments suggest a strong outlook for future growth.
Performance & Financial Health Analysis: Labiana Health S.A vs Almirall S.A
| Metric | LAB | ALM |
|---|---|---|
| Market Information | ||
| Market Cap | €28.89M | €2.49B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 2,015 | 86,754 |
| 90 Day Avg. Volume | 2,927 | 121,287 |
| Last Close | €4.06 | €11.38 |
| 52 Week Range | €1.86 - €4.40 | €8.03 - €11.66 |
| % from 52W High | -7.73% | -2.40% |
| All-Time High | €4.40 (Sep 02, 2025) | €19.09 (Dec 28, 2015) |
| % from All-Time High | -7.73% | -40.39% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.10% |
| Quarterly Earnings Growth | N/A | -0.38% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.02% |
| Operating Margin (TTM) | 0.03% | 0.03% |
| Return on Equity (TTM) | 0.07% | 0.01% |
| Debt to Equity (MRQ) | 1,378.08 | 26.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €0.67 | €6.81 |
| Cash per Share (MRQ) | €0.02 | €1.51 |
| Operating Cash Flow (TTM) | €7.19M | €152.00M |
| Levered Free Cash Flow (TTM) | €6.02M | €39.89M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.67% |
| Last 12-Month Dividend | N/A | €0.18 |
Valuation & Enterprise Metrics Analysis: Labiana Health S.A vs Almirall S.A
| Metric | LAB | ALM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 104.00 | 116.00 |
| Forward P/E | 4.44 | 25.22 |
| PEG Ratio | N/A | 25.22 |
| Price to Sales (TTM) | 0.45 | 2.36 |
| Price to Book (MRQ) | 6.26 | 1.70 |
| Market Capitalization | ||
| Market Capitalization | €28.89M | €2.49B |
| Enterprise Value | €57.54M | €2.53B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.87 | 2.40 |
| Enterprise to EBITDA | 6.18 | 14.14 |
| Risk & Other Metrics | ||
| Beta | -0.39 | 0.34 |
| Book Value per Share (MRQ) | €0.67 | €6.81 |
Financial Statements Comparison: Labiana Health S.A vs Almirall S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LAB | ALM |
|---|---|---|
| Revenue/Sales | €10.58M | €286.10M |
| Cost of Goods Sold | €-5.06M | €94.20M |
| Gross Profit | €15.63M | €191.90M |
| Research & Development | N/A | €35.50M |
| Operating Income (EBIT) | €9.07M | €34.20M |
| EBITDA | €11.11M | €72.90M |
| Pre-Tax Income | €7.05M | €35.80M |
| Income Tax | €0 | €14.20M |
| Net Income (Profit) | €7.05M | €21.60M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LAB | ALM |
|---|---|---|
| Cash & Equivalents | €6.74M | €374.40M |
| Total Current Assets | €28.70M | €764.60M |
| Total Current Liabilities | €22.16M | €334.70M |
| Long-Term Debt | €27.24M | €341.50M |
| Total Shareholders Equity | €2.57M | €1.50B |
| Retained Earnings | €253,449 | N/A |
| Property, Plant & Equipment | €1.27M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LAB | ALM |
|---|---|---|
| Operating Cash Flow | €-7.21M | €35.70M |
| Capital Expenditures | €-397,000 | N/A |
| Free Cash Flow | €-2.17M | €12.20M |
| Debt Repayment | €-232,000 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LAB | ALM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 2,015 | 86,754 |
| Average Daily Volume (90 Day) | 2,927 | 121,287 |
| Shares Outstanding | 7.22M | 213.24M |
| Float Shares | N/A | 78.20M |
| % Held by Insiders | 0.72% | 0.65% |
| % Held by Institutions | 0.00% | 0.16% |
Dividend Analysis & Yield Comparison: Labiana Health S.A vs Almirall S.A
| Metric | LAB | ALM |
|---|---|---|
| Last 12-Month Dividend | N/A | €0.18 |
| Last 12-Month Dividend Yield | N/A | 1.67% |
| 3-Year Avg Annual Dividend | N/A | €0.18 |
| 3-Year Avg Dividend Yield | N/A | 1.97% |
| 3-Year Total Dividends | N/A | €0.54 |
| Ex-Dividend Date | N/A | May 15, 2025 |